Figure 5From: Development and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study Mean (±SD) Plasma Concentration versus time of montelukast (A), gliclazide (B) and nifedipine (C) following simultaneous administration of montelukast (10 mg), gliclazide (80 mg) and nifedipine (20 mg) Tablets to six healthy male volunteers. Back to article page